- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00292773
Weight Reduction Surgery and Ovarian Function
The Effect of Weight Reduction Surgery on Ovarian Function in Obese Anovulatory Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
We aim to recruit 30 patients suffering from chronic anovulation, with a body mass index of 35 or more, who failed to achieve weight reduction with other methods such as orlistat, metformin, diet and exercise.
Patients will be approached by one of the investigators in the infertility clinics and the assisted conception unit of the Royal Hallamshire hospital. Consent will be obtained by one of the designated investigators. The consent form has been designed in accordance with the guidelines of the central office for research and ethics committees (COREC). A patient information leaflet will be supplied and has been designed according to the COREC guidelines.
Patients will have a baseline history, clinical examination, hormonal profile (FSH/LH, fasting Insulin/glucose ratio, androgen profile, day 21 serum progesterone, serum leptin and ghrelin levels) ultrasound examination (ovarian volume and antral follicle count), including Doppler blood flow study (ovarian stromal velocity).
Patients will be offered laparoscopic gastric bypass surgery by Mr Roger Ackroyd, in line with the current recommendation for gastric surgery according to NICE guidelines i.e. patients with a BMI over 40 or a BMI over 35 with at least one co-morbidity. Patients will be reviewed monthly for six months. At each visit the following will be recorded:
- Weight, menstrual diary.
- Hormonal profile (FSH/LH, fasting Insulin/glucose ratio, androgen profile, day 21 serum progesterone, serum leptin and ghrelin levels).
- Doppler of ovarian stroma (Pulsitility index, Peak velocity), ovarian volume and antral follicle count
- Review of symptomatology especially androgenic symptoms.
End point:
Completion of six months follow up.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Sheffield, United Kingdom, S10 2SF
- Jessop Wing, Royal Hallamshire Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Anovulation or irregular ovulation as determined by the following clinical or laboratory features:
Clinical:
i. Irregular cycles (not 25-35 days) ii. Amenorrhoea (more than six months).
- Biochemical: Day 21 or midleuteal serum progesterone of less than 30mmol/l.
- BMI of 35 or more.
- Age between 18 and 45.
Exclusion Criteria:
Contraindication for bypass surgery:
i. Medically unfit ii. Psychologically unfit iii. Strong family history of gastric cancer
- Insulin dependant diabetes or patients on oral hypoglycaemics. Insulin resistance and impaired glucose tolerance however, are not exclusion criteria.
- Concomitant endocrine disorders including thyroid disease and Cushing syndrome.
- Patients on steroid therapy.
- Patients who have had one or both ovaries removed.
- Biochemical evidence of ovarian failure i.e. FSH of 20 IU or more.
- Patients who have had hysterectomy.
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Investigators
- Study Chair: Professor TC Li, FRCOG,MD, STH
- Study Chair: Professor William Ledger, FRCOG,D Phil, Sheffield University
Study record dates
Study Major Dates
Study Start
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STH14006
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.